Dandu; Reddeppa Reddy
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dandu; Reddeppa Reddy.The latest application filed is for "substituted 4-benzyl and 4-benzoyl piperidine derivates".
- Dandu; Reddeppa Reddy - Downingtown PA
- Dandu; Reddeppa Reddy - Downington PA
- DANDU; Reddeppa Reddy - San Diego CA
| Patent | Date |
|---|---|
| Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates App 20220081411 - Becknell; Nadine C. ; et al. | 2022-03-17 |
| 1,4-Substituted Piperidine Derivatives App 20210230116 - Becknell; Nadine C. ; et al. | 2021-07-29 |
| Substituted 4-benzyl and 4-benzoyl piperidine derivatives Grant 10,919,875 - Becknell , et al. February 16, 2 | 2021-02-16 |
| 1,4-substituted piperidine derivatives Grant 10,851,057 - Becknell , et al. December 1, 2 | 2020-12-01 |
| Substituted 4-benzyl And 4-benzoyl Piperidine Derivatives App 20200031797 - BECKNELL; Nadine C. ; et al. | 2020-01-30 |
| 1,4-substituted Piperidine Derivatives App 20190152913 - Becknell; Nadine C. ; et al. | 2019-05-23 |
| 1,4-substituted piperidine derivatives Grant 10,221,135 - Becknell , et al. | 2019-03-05 |
| 1,4-substituted Piperidine Derivatives App 20180179159 - Becknell; Nadine C. ; et al. | 2018-06-28 |
| 1,4-substituted piperidine derivatives Grant 9,902,696 - Becknell , et al. February 27, 2 | 2018-02-27 |
| Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20170320853 - DANDU; Reddeppa Reddy ; et al. | 2017-11-09 |
| Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,745,283 - Dandu , et al. August 29, 2 | 2017-08-29 |
| Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20170050949 - Dandu; Reddeppa Reddy ; et al. | 2017-02-23 |
| 1,4-substituted Piperidine Derivatives App 20160368874 - Becknell; Nadine C. ; et al. | 2016-12-22 |
| Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,522,902 - Dandu , et al. December 20, 2 | 2016-12-20 |
| Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,120,778 - Dandu , et al. September 1, 2 | 2015-09-01 |
| Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20150210670 - Dandu; Reddeppa Reddy ; et al. | 2015-07-30 |
| Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20150209358 - Dandu; Reddeppa Reddy ; et al. | 2015-07-30 |
| Uracil derivatives as AXL and c-MET kinase inhibitors Grant 9,029,538 - Dandu , et al. May 12, 2 | 2015-05-12 |
| Uracil Derivatives As Axl And C-met Kinase Inhibitors App 20140275077 - Dandu; Reddeppa Reddy ; et al. | 2014-09-18 |
| Multicyclic compounds and the use thereof Grant 8,716,493 - Chatterjee , et al. May 6, 2 | 2014-05-06 |
| Substituted Spirocyclic Piperidine Derivatives As Histamine-3 (h3) Receptor Ligands App 20130310389 - Dandu; Reddeppa reddy ; et al. | 2013-11-21 |
| Substituted spirocyclic piperidine derivatives as histamine-3 (H.sub.3) receptor ligands Grant 8,524,713 - Dandu , et al. September 3, 2 | 2013-09-03 |
| Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands Grant 8,513,232 - Bacon , et al. August 20, 2 | 2013-08-20 |
| Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands App 20110098269 - Becknell; Nadine C. ; et al. | 2011-04-28 |
| Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands App 20110071131 - Bacon; Edward R. ; et al. | 2011-03-24 |
| Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands App 20100298332 - Dandu; Reddeppa reddy ; et al. | 2010-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 